ftInvstr
SYNCOMF · Healthcare ₹19.99 -4.85% Mkt Cap ₹1889 Cr

SYNCOMF

Healthcare Drug Manufacturers - Specialty & Generic
₹19.99
-4.85% today · 30d -14.21%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SYNCOMF. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹126 Cr
+7.38% YoY
NET PROFIT
₹25 Cr
+57.71% YoY
OPM
25.52%
+7.76pp YoY
EPS
₹0.26
PE 21.38
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-49.9%, h2=-50.0%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SYNCOMF21.3819.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
75
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 90
Valuation REASONABLE 60
Growth STEADY 67
Profitability HIGH 85
Technicals NEUTRAL 60
Risk LOW 90
Key Stats
TTM PE
21.38
P/B
4.52
52W HIGH
₹27.49
OFF HIGH
-27.28%
DIV YIELD
0.5%
MKT CAP
₹1889 Cr
◉ Active Signals
MACDBearish-0.0861
RSI(14)Neutral45.61
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SYNCOMF and at what entry.

Sign up freeSign in